William Hrushesky to Animals
This is a "connection" page, showing publications William Hrushesky has written about Animals.
Connection Strength
0.783
-
Cancer as a changed tissue's way of life (when to treat, when to watch and when to think). Future Oncol. 2016 Mar; 12(5):647-57.
Score: 0.038
-
Measuring stem cell circadian rhythm. Methods Mol Biol. 2015; 1235:81-95.
Score: 0.036
-
Circadian transcription profile of mouse breast cancer under light-dark and dark-dark conditions. Cancer Genomics Proteomics. 2010 Nov-Dec; 7(6):311-22.
Score: 0.027
-
Clock genes and cancer. Integr Cancer Ther. 2009 Dec; 8(4):303-8.
Score: 0.025
-
Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther. 2009 Dec; 8(4):387-97.
Score: 0.025
-
Circadian time-dependent tumor suppressor function of period genes. Integr Cancer Ther. 2009 Dec; 8(4):309-16.
Score: 0.025
-
Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome. Breast Cancer Res Treat. 2009 Nov; 118(2):345-59.
Score: 0.025
-
The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009 Oct; 26(7):1323-39.
Score: 0.025
-
Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem. 2009 Mar; 145(3):289-97.
Score: 0.023
-
Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res. 2008 Nov; 6(11):1786-93.
Score: 0.023
-
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 2009 Sep; 117(2):423-31.
Score: 0.023
-
Seasonal modulation of post-resection breast cancer metastasis. Breast Cancer Res Treat. 2008 Sep; 111(2):219-28.
Score: 0.022
-
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006 Aug; 5(8):2023-33.
Score: 0.020
-
Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int J Exp Pathol. 2006 Jun; 87(3):227-36.
Score: 0.020
-
Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther. 2005 Jul; 4(7):1065-75.
Score: 0.018
-
Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005 May; 91(1):47-60.
Score: 0.018
-
Sex cycle modulates cancer growth. Breast Cancer Res Treat. 2005 May; 91(1):95-102.
Score: 0.018
-
Re: Melatonin and breast cancer: a prospective study. J Natl Cancer Inst. 2004 Jun 02; 96(11):888-9.
Score: 0.017
-
Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat. 2002 Sep; 75(1):65-72.
Score: 0.015
-
Circadian coordination of cancer growth and metastatic spread. Int J Cancer. 1999 Oct 29; 83(3):365-73.
Score: 0.012
-
Fertility maintenance and 5-fluorouracil timing within the mammalian fertility cycle. Reprod Toxicol. 1999 Sep-Oct; 13(5):413-20.
Score: 0.012
-
Menstrual timing of breast cancer surgery. Am J Surg. 1998 Mar; 175(3):245-61.
Score: 0.011
-
Menstrual cycle timing of breast cancer resection. Recent Results Cancer Res. 1996; 140:27-40.
Score: 0.010
-
Circadian rhythms and cancer chemotherapy. Crit Rev Eukaryot Gene Expr. 1996; 6(4):299-343.
Score: 0.010
-
Square pegs in round holes. Int J Cancer. 1995 Sep 04; 62(5):651-2.
Score: 0.009
-
Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest. 1995 Apr; 95(4):1650-9.
Score: 0.009
-
Cancer chronotherapy: is there a right time in the day to treat? J Infus Chemother. 1995; 5(1):38-43.
Score: 0.009
-
Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality. J Exp Med. 1994 Sep 01; 180(3):1059-65.
Score: 0.009
-
Circadian pharmacodynamics of anticancer therapies. Clin Chem. 1993 Nov; 39(11 Pt 2):2413-8.
Score: 0.008
-
Circadian cancer therapy. J Clin Oncol. 1993 Jul; 11(7):1403-17.
Score: 0.008
-
Circadian cancer pharmacodynamics. Ann Ist Super Sanita. 1993; 29(4):705-10.
Score: 0.008
-
The multifrequency (circadian, fertility cycle, and season) balance between host and cancer. Ann N Y Acad Sci. 1991; 618:228-56.
Score: 0.007
-
Temporally optimizable delivery systems--sine qua non for molecular medicine. Preface. Ann N Y Acad Sci. 1991; 618:xi-xvii.
Score: 0.007
-
Prohibitin as an oxidative stress biomarker in the eye. Int J Biol Macromol. 2010 Dec 01; 47(5):685-90.
Score: 0.007
-
Cleavage of the retinal pigment epithelium-specific protein RPE65 under oxidative stress. Int J Biol Macromol. 2010 Aug 01; 47(2):104-8.
Score: 0.006
-
Melatonin reprogrammes proteomic profile in light-exposed retina in vivo. Int J Biol Macromol. 2010 Aug 01; 47(2):255-60.
Score: 0.006
-
Menstrual influence on surgical cure of breast cancer. Lancet. 1990 Apr 21; 335(8695):984.
Score: 0.006
-
Determination of the therapeutic index of floxuridine by its circadian infusion pattern. J Natl Cancer Inst. 1990 Mar 07; 82(5):386-93.
Score: 0.006
-
Local immunosuppression of the vascularized graft. Surgery. 1990 Feb; 107(2):209-14.
Score: 0.006
-
Pharmacodynamics of local heparin infusion in a canine renal allograft model. J Pharmacol Exp Ther. 1990 Feb; 252(2):733-8.
Score: 0.006
-
Cancer chronotherapy: a drug delivery challenge. Prog Clin Biol Res. 1990; 341A:1-10.
Score: 0.006
-
In this issue: circadian disruption and cancer. Integr Cancer Ther. 2009 Dec; 8(4):295-7.
Score: 0.006
-
Neuroprotective role of erythropoietin by antiapoptosis in the retina. J Neurosci Res. 2009 Aug 01; 87(10):2365-74.
Score: 0.006
-
Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst. 1989 Jan 18; 81(2):135-45.
Score: 0.006
-
Circadian rhythm and seasonal dependence in the toxicological response of mice to epirubicin. Invest New Drugs. 1988 Dec; 6(4):273-83.
Score: 0.006
-
Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential. J Natl Cancer Inst. 1988 Oct 05; 80(15):1232-7.
Score: 0.006
-
Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage. Surgery. 1988 Aug; 104(2):398-403.
Score: 0.006
-
Estrous influence on surgical cure of a mouse breast cancer. J Exp Med. 1988 Jul 01; 168(1):73-83.
Score: 0.006
-
The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008 Nov; 19(11):1821-8.
Score: 0.006
-
Methylene blue protects intestinal mucosa from free radical-mediated sublethal radiation damage. Free Radic Biol Med. 1988; 5(4):207-13.
Score: 0.005
-
Circadian susceptibility-resistance cycles to radiation and their manipulability by methylene blue. Pharmacol Ther. 1988; 39(1-3):397-402.
Score: 0.005
-
Timing may be a critical factor in drug therapy. Cancer Treat Rep. 1987 Dec; 71(12):1321.
Score: 0.005
-
Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer. 2007 Nov 01; 110(9):1880-8.
Score: 0.005
-
Circadian pattern of continuous FUDR infusion reduces toxicities. Prog Clin Biol Res. 1987; 227B:357-73.
Score: 0.005
-
Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol Int. 1986; 3(1):55-64.
Score: 0.005
-
Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers. J Exp Ther Oncol. 2006; 6(1):73-84.
Score: 0.005
-
Cyclosporine timing and kidney damage. N Engl J Med. 1985 Jul 18; 313(3):184.
Score: 0.005
-
Circadian timing of cancer chemotherapy. Science. 1985 Apr 05; 228(4695):73-5.
Score: 0.005
-
Modifying intracellular redox balance: an approach to improving therapeutic index. Lancet. 1985 Mar 09; 1(8428):565-7.
Score: 0.005
-
Circadian toxicology of cyclosporin. Toxicol Appl Pharmacol. 1985 Jan; 77(1):181-5.
Score: 0.004
-
24-hour mean pulse. Simple predictor of doxorubicin-induced cardiac damage. Am J Med. 1984 Sep; 77(3):399-406.
Score: 0.004
-
Creation of a stable mammary tumor cell line that maintains fertility-cycle tumor biology of the parent tumor. In Vitro Cell Dev Biol Anim. 2004 Jul-Aug; 40(7):187-95.
Score: 0.004
-
Circadian mesor of recumbent pulse--cost-effective predictor of doxorubicin-induced congestive heart failure. Chronobiol Int. 1984; 1(1):59-66.
Score: 0.004
-
The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
Score: 0.004
-
Circadian time dependence of cisplatin urinary kinetics. Clin Pharmacol Ther. 1982 Sep; 32(3):330-9.
Score: 0.004
-
Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats. Cancer Res. 1982 Mar; 42(3):945-9.
Score: 0.004
-
Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Jpn J Cancer Res. 2001 Mar; 92(3):328-36.
Score: 0.003
-
Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage. Int J Cancer. 2000 Nov 01; 88(3):479-85.
Score: 0.003
-
Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Exp Hematol. 1998 Jun; 26(6):523-33.
Score: 0.003
-
Current status of the therapy of advanced renal carcinoma. J Surg Oncol. 1977; 9(3):277-88.
Score: 0.003
-
Irreversible inactivation of interleukin 2 in a pump-based delivery environment. Proc Natl Acad Sci U S A. 1996 May 28; 93(11):5460-5.
Score: 0.002
-
Evaluation of chemotherapeutic agents in a new murine renal carcinoma model. J Natl Cancer Inst. 1974 Apr; 52(4):1117-22.
Score: 0.002
-
Investigation of a new renal tumor model. J Surg Res. 1973 Nov; 15(5):327-36.
Score: 0.002
-
A murine renal cell carcinoma. J Natl Cancer Inst. 1973 Apr; 50(4):1013-25.
Score: 0.002
-
Carcinogenicity of ethylmethanesulfonate. J Natl Cancer Inst. 1972 Oct; 49(4):1077-83.
Score: 0.002
-
Mizoribine pharmacokinetics and pharmacodynamics in a canine renal allograft model of local immunosuppression. Transplantation. 1992 Jan; 53(1):12-9.
Score: 0.002
-
Local prednisolone infusion of canine renal allografts. Transplantation. 1989 Dec; 48(6):1072-5.
Score: 0.002
-
Local immunosuppression with reduced systemic toxicity in a canine renal allograft model. Transplantation. 1989 Dec; 48(6):936-43.
Score: 0.002
-
Feasibility of vascular catheter placement for intrarenal infusion in a canine autotransplant model. Transplant Proc. 1989 Feb; 21(1 Pt 1):1125-6.
Score: 0.001
-
Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats. Oncology. 1985; 42(1):48-54.
Score: 0.001
-
Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. Cancer Treat Rep. 1982 Nov; 66(11):1933-8.
Score: 0.001
-
Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration. Eur J Cancer Clin Oncol. 1982 May; 18(5):471-7.
Score: 0.001
-
Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res. 1982 Mar; 42(3):950-5.
Score: 0.001
-
Time-varying effects in mice and rats of several synthetic ACTH preparations. Chronobiologia. 1980 Apr-Jun; 7(2):211-26.
Score: 0.001
-
Synthetic adrenocorticotropin for optimizing murine circadian chronotolerance for adriamycin. Chronobiologia. 1980 Apr-Jun; 7(2):227-44.
Score: 0.001
-
Influence of hormone therapy on rats treated with the carcinogen ethylmethanesulphonate. Res Commun Chem Pathol Pharmacol. 1974 Jan; 7(1):25-30.
Score: 0.001